TERMS AND CONDITIONS
Eligibility Criteria:
You may be eligible for the EUCRISA Copay Savings Program if you currently use private or commercial health insurance to cover a portion of your medication costs for EUCRISA.
TERMS AND CONDITIONS
By using the Pfizer Dermatology Patient Access™ Copay Savings Card, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:
Your savings card(s) have been emailed to: {{emailTo}}
Your Copay card download should begin now. Each offer has a unique identification number, so please make sure to distribute one to each patient.
If your download does not start, please click here to download again.
For questions or additional support, call 1-877-548-1739, write to Pfizer Inc., at PO Box 29387, Mission, KS 66201, or visit the EUCRISA website at www.eucrisa.com.
A savings and support program for your patients to help them with their access to EUCRISA
Favorable access on many plans nationwide and is available at the lowest branded copay for many commercial and Medicare patients.
EUCRISA (crisaborole) is indicated for topical treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
EUCRISA is for topical use only and is not for ophthalmic, oral, or intravaginal use. For more information, please view the full prescribing information here.
Contraindications
EUCRISA is contraindicated in patients with known hypersensitivity to crisaborole or any component of the formulation.
Warnings and Precautions
Hypersensitivity reactions, including contact urticaria, have occurred in patients treated with EUCRISA and should be suspected in the event of severe pruritus, swelling, and erythema at the application site or at a distant site. Discontinue EUCRISA immediately and initiate appropriate therapy if signs and symptoms of hypersensitivity occur.
Adverse Reactions
The most common treatment-related adverse reaction occurring in clinical trials was application site pain, such as burning or stinging.
Please see Full Prescribing Information and Patient Information